Abstract
Autoimmune diseases are characterized by autoantibody formation and visceral involvement that is often of an inflammatory nature. Rheumatoid arthritis (RA) is a classic immune complex disease characterized by antibody formation and inflammatory arthritis. Extra-articular manifestations of RA may also occur. Systemic sclerosis (scleroderma, SSc) is another autoimmune disease and includes autoantibody formation as well as visceral involvement; however, the visceral manifestations in SSc relate to excessive collagen deposition and/or a vasculopathy. Internal organ inflammatory changes are typically seen in other autoimmune diseases; however, these do not typically occur in SSc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lawrence, R.C., et al, Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998. 41(5): pp. 778–99.
MacGregor, A.J., et al, Rheumatology, Fourth edn, M. Hochberg (ed.). Elsevier, Philadelphia, PA. 2008, pp.755–61.
Doran, M.F., et al, Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002. 46(3): pp. 625–31.
Vallbracht, I. and K. Helmke, Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun Rev. 2005. 4(6): pp. 389–94.
McQueen, F.M. and M. Ostergaard, Established rheumatoid arthritis – New imaging modalities. Best Pract Res Clin Rheumatol, 2007. 21(5): pp. 841–56.
Combe, B. Early rheumatoid arthritis: Strategies for prevention and management. Best Pract Res Clin Rheumatol, 2007. 21: pp. 27–42.
Steen, V.D. and T.A. Medsger, Jr., The palpable tendon friction rub: An important physical examination finding in patients with systemic sclerosis. Arthritis Rheum, 1997. 40(6): pp. 1146–51.
Masi, A.T., G.P. Rodnan, and T.A. Medsger, Jr., et al, Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum, 1980. 23: pp. 581–90.
Steen, V.D., D.L. Powell, and T.A. Medsger, Jr., Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum, 1988. 31(2): pp. 196–203.
Blockmans, D., G. Beyens, and R. Verhaeghe, Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheum, 1996. 15(2): pp. 148–53.
Reimer, G., et al, Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum, 1988. 31(4): pp. 525–32.
Steen, V.D., et al, Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum, 1994. 37(9): pp. 1283–9.
Steen, V.D., et al, Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum, 1992. 35(7): pp. 765–70.
Tashkin, D.P., et al, Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med, 2006. 354(25): pp. 2655–66.
Steen, V.D. and T.A. Medsger, Jr., Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum, 1998. 41(9): pp. 1613–19.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bolster, M.B. (2009). Autoimmune Diseases. In: Mahmoudi, M. (eds) Challenging Cases in Allergy and Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-443-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-60327-443-2_18
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-442-5
Online ISBN: 978-1-60327-443-2
eBook Packages: MedicineMedicine (R0)